Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
Author(s) -
Robert O. Bonow,
Gerald Maurer,
Kerry L. Lee,
Thomas A. Holly,
Philip F. Binkley,
Patrice DesvigneNickens,
Jarosław Dróżdż,
Pedro Sílvio Farsky,
Arthur M. Feldman,
Torsten Doenst,
Robert E. Michler,
Daniel S. Berman,
José Carlos Nicolau,
Patricia A. Pellikka,
Krzysztof Wróbel,
Nasri Alotti,
Federico M. Asch,
Liliana Favaloro,
Lilin She,
Eric J. Velazquez,
Robert H. Jones,
Julio A. Panza
Publication year - 2011
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1100358
Subject(s) - medicine , cardiology , hazard ratio , coronary artery disease , dobutamine , artery , confidence interval , randomized controlled trial , hemodynamics
The assessment of myocardial viability has been used to identify patients with coronary artery disease and left ventricular dysfunction in whom coronary-artery bypass grafting (CABG) will provide a survival benefit. However, the efficacy of this approach is uncertain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom